1: Li J, Yakushi T, Parlati F, Mackinnon AL, Perez C, Ma Y, Carter KP, Colayco S, Magnuson G, Brown B, Nguyen K, Vasile S, Suyama E, Smith LH, Sergienko E, Pinkerton AB, Chung TDY, Palmer AE, Pass I, Hess S, Cohen SM, Deshaies RJ. Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11. Nat Chem Biol. 2017 May;13(5):486-493. doi: 10.1038/nchembio.2326. Epub 2017 Feb 28. PMID: 28244987; PMCID: PMC5570473.
2: Moon S, Muniyappan S, Lee SB, Lee BH. Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases. Int J Mol Sci. 2021 Jun 9;22(12):6213. doi: 10.3390/ijms22126213. PMID: 34207520; PMCID: PMC8226605.
3: Lee HJ, Lee DM, Seo MJ, Kang HC, Kwon SK, Choi KS. PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca2+ Imbalance. Int J Mol Sci. 2022 Feb 28;23(5):2648. doi: 10.3390/ijms23052648. PMID: 35269789; PMCID: PMC8910635.
4: Luu AK, Cadieux M, Wong M, Macdonald R, Jones R, Choi D, Oblak M, Brisson B, Sauer S, Chafitz J, Warshawsky D, Wood GA, Viloria-Petit AM. Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle. Int J Mol Sci. 2022 Mar 17;23(6):3256. doi: 10.3390/ijms23063256. PMID: 35328679; PMCID: PMC8953151.
5: Sherman DJ, Li J. Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease. Molecules. 2020 Feb 5;25(3):671. doi: 10.3390/molecules25030671. PMID: 32033280; PMCID: PMC7037493.
6: Kumar V, Naumann M, Stein M. Computational Studies on the Inhibitor Selectivity of Human JAMM Deubiquitinylases Rpn11 and CSN5. Front Chem. 2018 Oct 9;6:480. doi: 10.3389/fchem.2018.00480. PMID: 30356695; PMCID: PMC6189316.
7: Yu W, Li J, Wang Q, Wang B, Zhang L, Liu Y, Tang M, Xu G, Yang Z, Wang X, Zhang J, Liu Y, Shi G. Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel. Prostate. 2019 Aug;79(11):1304-1315. doi: 10.1002/pros.23838. Epub 2019 Jun 18. PMID: 31212367.
8: Spataro V, Buetti-Dinh A. POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells. Br J Cancer. 2022 Sep;127(5):788-799. doi: 10.1038/s41416-022-01829-z. Epub 2022 May 2. PMID: 35501388; PMCID: PMC9428165.
9: Bustamante HA, Cereceda K, González AE, Valenzuela GE, Cheuquemilla Y, Hernández S, Arias-Muñoz E, Cerda-Troncoso C, Bandau S, Soza A, Kausel G, Kerr B, Mardones GA, Cancino J, Hay RT, Rojas-Fernandez A, Burgos PV. The Proteasomal Deubiquitinating Enzyme PSMD14 Regulates Macroautophagy by Controlling Golgi-to- ER Retrograde Transport. Cells. 2020 Mar 23;9(3):777. doi: 10.3390/cells9030777. PMID: 32210007; PMCID: PMC7140897.
10: Li J, Zhang Y, Da Silva Sil Dos Santos B, Wang F, Ma Y, Perez C, Yang Y, Peng J, Cohen SM, Chou TF, Hilton ST, Deshaies RJ. Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11. Cell Chem Biol. 2018 Nov 15;25(11):1350-1358.e9. doi: 10.1016/j.chembiol.2018.07.012. Epub 2018 Aug 23. PMID: 30146242; PMCID: PMC6309308.